BioCentury
ARTICLE | Clinical News

AciPhex regulatory update

January 7, 2013 8:00 AM UTC

On Dec. 11, 2012, Eisai said FDA granted pediatric exclusivity for Aciphex rabeprazole, which extends patent protection for the drug by 6 months to Nov. 8, 2013. A 20 mg tablet formulation of Aciphex ...